Showing results (6241-6250 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|September 29, 2023
Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to EverolimusYuko Nakayama, Daichi Enomoto, Kazuhiro Yamamoto, et al.
Anticancer Research|September 29, 2023
Mesonephric-like Adenocarcinoma of the Uterine Corpus: Clinicopathological and Prognostic Significance of L1 Cell Adhesion Molecule (L1CAM) Over-expressionSuho Park, Yunjoo Cho, Hyun-Soo Kim
Anticancer Research|September 29, 2023
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective StudyNobuki Furubayashi, Akinori Minato, Takahito Negishi, et al.
Anticancer Research|June 23, 2023
Association Between 18F-Fluorodeoxyglucose Uptake and Mutation Status of Epidermal Growth Factor Receptor in Sinonasal Tract CancerHidenori Suzuki, Eiichi Sasaki, Tsuneo Tamaki, et al.
Anticancer Research|June 23, 2023
Metastasectomy Improves Overall Survival in Metastatic Renal Cell Carcinoma: A Retrospective Cohort StudyJiun-Kai Chiou, Li-Wen Chang, Jian-Ri Li, et al.
Anticancer Research|June 23, 2023
Treatment Algorithm for Patients With Gastric Adenocarcinoma: Austrian Consensus on Systemic Therapy - An UpdateEwald Wöll, Arno Amann, Wolfgang Eisterer, et al.
Anticancer Research|June 23, 2023
FOXJ3 Regulates Cell Proliferation and Motility Through Modulating Snail Expression in Breast Cancer CellsYulyeong Seo, Jimin Lee, Jinho Kim, et al.
Anticancer Research|June 23, 2023
Optimal Number of Needle Applicators Inserted in Combined Intracavitary and Interstitial Brachytherapy for Cervical CancerRyuta Hirai, Tomohiro Ohta, Mitsunobu Igari, et al.
Anticancer Research|June 23, 2023
Imipramine Induces Apoptosis and Inhibits the Metastatic Potential of Triple-negative Breast Cancer CellsSheng-Kai Chen, Wei Lee, Yu-Ching Li, et al.
Anticancer Research|June 23, 2023
Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated ClustersKazuhiko Yoshimatsu, Teppei Kono, Masaya Satake, et al.
Pageof 2,589